A novel tumor immunotherapy-related signature for risk stratification, prognosis prediction, and immune status in hepatocellular carcinoma

Immunotherapy as a strategy to deal with cancer is increasingly being used clinically, especially in hepatocellular carcinoma (HCC). We aim to create an immunotherapy-related signature that can play a role in predicting HCC patients’ survival and therapeutic outcomes. Immunotherapy-related genes wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jianping, Xi, Lefeng, Zhang, Dechen, Gao, Feipei, Wang, Liqin, Yang, Guangying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618198/
https://www.ncbi.nlm.nih.gov/pubmed/37907783
http://dx.doi.org/10.1038/s41598-023-46252-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618198/
https://www.ncbi.nlm.nih.gov/pubmed/37907783
http://dx.doi.org/10.1038/s41598-023-46252-3

Ejemplares similares